However, the performance of methylated ADHFE1 for adenoma detection was poorer than that of methylated SDC2 (Table 3 and Table 4), suggesting that further refinement of our biomarker selection approach for precancer detection is necessary. The gene discussed is SDC2; the disease is adenoma.